AbbVie Joins UChicago to Talk Oncology Research, Ongoing Collaboration, and Opportunities for Expansion

The annual UChicago-AbbVie Research Symposium in August celebrated another successful year of the strategic partnership – bringing together academia and industry to exchange new ideas and drive innovation. The event…

AbbVie, University of Chicago Symposium to Showcase Latest Oncology Research Efforts

The UChicago-AbbVie Research Symposium celebrates another successful year of strategic partnership, showcasing select innovative research efforts in oncology. Taking place Friday, August 19, 2022, the symposium aims to stimulate…

AbbVie and UChicago Extend Collaboration to Support Preclinical Oncology Research

The University of Chicago and AbbVie have announced an extended collaboration agreement through 2025 to support preclinical oncology research. To date, the collaboration has led to novel insights related to…

In Era of Research Cuts, Romance Blossoming Much Earlier Between Universities and Big Pharma

Engineering new pharmaceuticals is risky, achingly slow and astronomically expensive. While the estimates of how much it costs to get a drug into patients' hands vary and are often disputed,…

AbbVie, U of C Choose First Batch of Cancer Research Projects

Pharmaceutical giant AbbVie and University of Chicago have picked their initial set of projects to research cancer, a deadly disease given a renewed focus under the Obama administration. They include…

AbbVie, University of Chicago Collaborate to Advance Cancer Research

The University of Chicago and AbbVie, a global biopharmaceutical company, have entered into a five-year collaboration agreement designed to improve the pace of discovery and advance medical research in oncology…